Save Company Number with airSlate SignNow

Save company number

what's up you guys welcome back to my channel in this video i'll be talking about t2 bio system ticker symbol tto this is one of the stock that has great potential to spike up in the price and i'll go over three things in this video the first one will be doing technical analysis of the stock price chart and the volume and how the stock has been trading lately as a second thing we'll also discuss about what the company does what the business looks like the revenue in q4 on audited numbers that the company disclosed and we'll also discuss about where the company is headed in terms of their business how much cash they have on hand and the third thing we'll talk about is analyst rating and the target price so watch the full video because this is going to be this video is going to be full of a lot of information and you definitely want to put this stock on your watch list now once again i am not a financial advisor and this is not a financial advice to buy or sell the stock so do your own due diligence and research before you buy or sell tto or any other stock this takes me a while to do the research and post the video so if you can click the like button that will be a great help also subscribe to my channel for future videos and share this video with your friends and family that will be greatly appreciated let's talk about t2 biosystems the stock has been trading at 1.99 the stock was down last trading session if you know already in last trading session most of the penny stocks were down and t2 biosystems tt00 was also one of them let's take a look at one day chart uh and the stock was trading around the range of two dollars went all the way up to two dollars and 17 cents and closed at 1.99 the deep might be a buying opportunity here but there is a great potential uh there is a great analyst forecast there is a great revenue on our auditor revenue that the company disclosed and i'll go over this in this video if you take a look at the five-day chart the stock is up by 3.65 in five days in one month it's 59.20 in six months the stock is up 19.88 or 33 cents and year to date the stock is up 50 so there's a great momentum in terms of the stock price and once again this is a penny stock penny stocks are risky investments i would never recommend you invest your entire portfolio in penny stocks because you can make a lot of money in penny stocks on the flip side you can lose them all not literally all of them but you can lose a lot of money in penny stock as well because it tends to be pretty volatile t2 biosystems is a very small company with the market cap of 294 million dollars the 52 week range for the stock price is 24 cents to 2.92 cents one day range though 1.99 to 2.19 cents and the previous close was two dollars and two cents this also represents represents a good buying opportunity the company has company is revenue positive in q3 2020 the revenue was 5.25 million in q2 the revenue was 2.55 million in q1 the revenue was 2.55 million however the net income is negative it's negative for 15 million dollars in q1 2020 the net income was negative 10.69 million in q2 2020 and in q3 the income was net income was negative 11.26 million the cost of revenue though is 10.80 million dollars but the company started booking more revenue and i'll go over this numbers very shortly let's take a look at what the company looks like in terms of their volume their volume in last trading session was 9.9 million almost 10 million where their average volume is 8.2 million now let's take a look at one year target for one year target for t2 bio systems is 3.18 cents let's take a look at the technical analysis and the chart of tto if you take a look at this is one day chart i want you to pay close attention at the red bar or the red line right here and the blue line suggests the stock price for one day now if you take a look at one day the stocks has peaks and valleys um the stock was down as down as two dollars and two cents from there it was spiked up to six two dollars and sixteen seventeen cents uh went down once again to two dollars and ten cents and went up to two dollars and seventeen cents and it had a big valley to two dollars and two cents and it went down to one dollars and ninety nine cents and it it was closed there the red line suggests the rsi now the rsi for one day was 39 which suggests that it is probably balanced or maybe over sold uh condition so there is a possibility looking at the one day chart from the technical analysis that the stock can spike up uh on monday however if you also take a look at five day chart there is a big big drop right here the stock was trading at two dollars and 82 cents and dropped all the way uh in a very short period of time to two dollars and four cents that suggests a pretty big drop and the rsi dropped from 60 to all the way 22. uh the stock went back up but it did not sustain there and got back down to 1.99 looking at the five-day chart for the five days rsi is 34. so five-day rsi also shows pretty close to oversold position not quite uh quite there when i take a look at the rsi i usually set the indicators around uh 80 and 20 as you see right here so based on based on this analysis it's not quite there yet oversold position if it was 20 it might be a better opportunity where the stock can spike up however this is not a bad bad bad rsi to think about like the stock and spike up now one thing you also want to notice here is last week all the penny stocks were down while all the penny stocks were down um this dto0 was also one of them but what i wanted to show you is this big drop right here now let's take a look at one more thing here let's take a look at the volume now the volume shows it the volume was 10 million 9.7 million on january 29th before there the wall before that the volume was 19.9 million almost 20 million and before that it was 37 million and before that it was 77 million so if you take a look at gradually the volume lowers down now i'm not sure if this was the effect of like people were trading a lot more in gme amc and all the stocks where they can get profit pretty quickly or maybe and i have seen this pattern in a couple of other stocks as well considering ctrm uh zom zom and the t2 biosystem tto is another stock that i also noticed the same pattern that the volume started decreasing while the short selling play was spiking up on the wall street and it does seem like people were trading a lot more into the speculative stocks but one thing to notice here as the volume has been gradually decreasing i'm not saying it's a it's a bad thing but when the volume spiked up from 17 million to 77 million the stock jumped from 185 to 292 almost three dollars now when the volume goes down it also impacts overall rsi um it also impacts like the overall stock price and whatnot and if you take a look at the volume right here when it was 6.1 million on january 8th the stock was 1.40 cents and when the volume spiked up to 80 million the stock went all the way up to 2.22 so i just wanted to share this with you as i noticed in my technical analysis now let's talk about what the company does we have a pretty decent volume technical analysis and the chart review as well if you made it this far i would recommend you also look into what the company does because it will help you making informed decision in your investment a t2 biosystems the company is saving lives and improving healthcare by empowering clinicians to effectively treat the patients pretty faster and their mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster they work every day to solve the critical needs in healthcare diagnostics and with innovative solutions that they have built around their game changing t2mr detection technology sepsis claims more lives annually than the breast cancer prostate cancer and aids combined and the company is focused on eradicating deaths due to sepsis by developing tools that helps identify most common and deadly sepsis causing pathogens faster than ever before and speed is critical in sepsis management the faster patient receives effective treatment the more likely that they get survive and they have better outcomes to live their life happily now what is sepsis let's take a look at what is sepsis according to mayo clinic sepsis is a potentially life-threatening condition that occurs when body's response to an infection damages its own tissues when the infection fighting process turn on the body they cause organs to function poorly and abnormally sepsis may progress to septic shock this is a dramatic drop in blood pressure that can lead to severe organ problems and health and sepsis is a very critical situation that can cause death too and the symptoms are changing in mental uh disorder or the mental state status uh systolic blood pressure changes as well that and and the third thing is respiratory rate higher than or equal to 22 breathe a minute and the company is effectively trying to solve the situation here the blood test provides that so so here the speed is one of the big big factor and their blood test provides actionable results within three to five hours which is pretty quick now if the blood test can give the results faster that means the patient can get treated faster if the patient gets the treatment faster there is higher chances that we can save the patient in critical condition now the company provides the actionable result within three to five hours the only other way to identify the species specific diagnosis requires blur culture which takes about one to five day more the t2 biosystem panels are getting patients on the right therapy faster expedited identification of negative tests results allowing rapid de-escalation of unneeded therapy in partnership with the hospitals around the world t2 biosystem technology is uniquely positioned to strike a huge blow to sepsis and the other hundreds of hundreds of thousands of lives that that is taken every year they have two big big uh product that the panels that they run on the automated t2dx instrument due to t2 bacteria and t2 candida and one of the great thing here that i want you to notice it's it's fda cleared blood tests they are the first and only fda cleared blood tests that identify sepsis causing pathogens without the weight for blood culture as the hospitals continue to adapt their technology it will also represent a paradigm shift that can potentially result into thousands of patients going home with their family after potentially avoidable and alternatives so this is one of the thing that they're working on they're also working with the current situation with cv resources t2 biosystems have developed the t2 sars cv panel in response to in response to the current health health situation that is going on the panel is commercially available and it was also awarded emergency use authorization by fda on august 31st 2020 the panel was validated in the accordance with the emergency use of authorization requirement from fda so this is one of the great thing that the company has been doing and that has more potential to also bring in more revenue at the right time the company is actively working on selling their products at the moment and i'll go over that as well now let's take a look at what their ceos just announced given the susceptibility of the critically lcb patients to develop bacteria or fungal co-infections and secondary infections that can lead to sepsis we believe our platform can be used to identify acute cv infections and optimize the outcomes for the patients under intensive care so this is one of the big thing and it got a very good response and with that we'll move on to the third uh third part of this video where we'll do review their numbers in terms of unaudited revenue uh analyst targets and the recommendations so now let's take a look at what they announced d2 biosystem announced fourth quarter and full year 2020 2020 result now the disclaimer here is this is not an audited results just yet so these are unaudited results but we can expect that when the audit it gets through the audit they will have very similar numbers as to what the company has announced at the moment let's take a look at the financial operation highlights preliminary unaudited fourth quarter 2020 total revenue is expected to be 7.82 million dollars now fourth quarter revenue so this is the magic number let's take a look at 7.8 million in q4 and compare that number with q3 in q3 the revenue was 5.25 million so there is a huge jump in terms of revenue quarter over quarter that includes the product revenue that they have for 5.8 million representing the growth they have strong cash on their hand unaudited cash cash equivalent current and long-term marketable securities and restricted cash total 52.7 million we already talked about this one year target here 3.18 uh where the stock is trading at two dollars and three point one eight three dollar and eighteen cents is more than fifty percent from where the stock is at here right now now if you take a look at the recommendations from the analysts there are five ratings two analysts are suggesting a strong buy one is saying bye and two are saying hold there is no one saying recommending underperforming the stock or sell let's take a look at the tip ranks analysis as well for t2 bio systems there are four analysts analyst rating available on t pranks where three are saying bye one is saying hold and zero is saying sell now the lowest price within this tip ranks and analyst rating is two dollars and forty cents now the average price is three dollars and ten cents where the high price is three dollars and fifty cents now if you think about this high price it is almost 75 percent from the current price because right now it's trading at two dollars if you add up 1.75 1.50 more or less it's almost 70 to 80 percent spike in the price in considering the high but even if you consider at low the stock has potential to gain more momentum in terms of price uh there was a big big drop in the stock price there is a lot of momentum there is also the short seller play that we have seen with gme and amc that might have impacted the stock that the people might wanted to trade in more speculative stocks and that's one of the reason why the volume has been decreasing will be able to figure out next week how the stock has been trading and what the momentum looks like i'll make sure to keep you guys all posted once again click the like button share this video with your friends and family also subscribe to my channel for future videos i'm not a financial advisor so do your own due diligence and research before you buy or sell tto thanks all i hope this helps you